AAN 2026 | Migraine comorbidities and multidisciplinary care: emerging evidence and treatment strategies

Thank you so much. That’s a very hard topic in headache medicine, always, and especially now when because of recent advances in research, we learn so much about the intersections between different comorbidities and migraine and other headache disorders. Example from the article you sent me from Cephalalgia, thank you so much. It was a wonderful editorial which we were able to do. We are grateful for our editor, Dr Simona Sacco of Cephalalgia and Cephalalgia Reports, who created wonderful collections there, including many people from the American Academy of Neurology, American Headache Society contributing articles. And all of these leading the way that we can holistically treat the person with migraine. Migraine and endometriosis, it seems there are strong connections there. And a question from this article is, can there be a role for prolactin and some therapies that would target prolactin, this hormone, to help in this situation to treat maybe migraine in such a person? So we have a lot of research in this direction. We did mention epilepsy and migraine, and now we have a whole section about that. We do know about migraine and vascular risk factors, especially for people with migraine with aura, a little bit more. And we do need to provide brain health for all. I really love it about the American Academy of Neurology, looking at a person as a whole, treating the whole role of conditions one might have. And then, of course, every day, a headache specialist would probably see someone who would point to the area of something about dentists. Do I have TMJ? All around the country, I hear that. And we have amazing oral health specialists we’re working together within our societies and we’re learning from each other and this editorial including neck pain, TMJ, and headache. So we’re going to talk about it at the American Academy of Neurology. So it will be a super exciting time for us when all specialties in neurology come together. And we’re also thinking about our colleagues in primary care, in orofacial pain, in pain medicine. So it’s an amazing collaboration which we need. And of course, I cannot say enough about behavioral – we have migraine and anxiety, for example, and we work very closely with our behavioral therapists and with other mental health specialists but we also have wonderful new treatments. We have all treatments which we incorporate in a new way of delivery, beautiful devices and colleagues for doing biofeedback, for example. We have neuromodulation devices, which is wonderful to use, especially when we try to avoid medication side effects as appropriate. So it’s an exciting time in headache medicine. And I know we’re at the top of our time. But please come to the American Academy of Neurology and we will see you there.

This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.